USPTO serial 79209897
BLC
Reviewed by CopyMark Law Group
Reg. 5461301Status 709
- Filing date
- Status date
- Registration date
- May 8, 2018
- Examiner
- FROMM, MARTHA L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BLC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Leonard
Michael J. Leonard Fox Rothschild LLP997 Lenox Drive, Bldg. 3Lawrenceville, NJ 08648-2311UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the diagnosis and treatment of cancer and illnesses and conditions, namely, cancer and precancerous lesions; veterinary preparations for the treatment of cancer and illnesses, namely, cancer and precancerous lesions in dogs, cats, horses, cattle, goats and sheep; sanitary preparations for medical purposes; dietetic foods adapted for medical use; medical plasters; materials for dressing, namely, bandages and gauze for dressing, occlusive dressing, occlusive self-adhesive dressing, occlusive foils for dressing wounds, and medical adhesive tapes; fungicides; adjuvants for medical purposes; amino acids for medical purposes; amino acids for veterinary purposes; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and precancerous lesions; chemical preparations for medical purposes for the treatment of cancer and precancerous lesions; chemical preparations for veterinary purposes for the treatment of cancer and precancerous lesions; chemico-pharmaceutical preparations for the treatment of cancer and precancerous lesions; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; cellulose esters for pharmaceutical purposes; medicines for human purposes for the treatment of cancer and precancerous lesions; medicines for veterinary purposes for the treatment of cancer and precancerous lesions; mineral salts for medical purposes | SECTION 71 - CANCELLED | — |
| 010 | Surgical apparatus and instruments for medical, dental, or veterinary use; surgical and medical, dental, and veterinary apparatus and instruments, namely, lamps and light source apparatus in the nature of light emitting diode devices for the detection, diagnosis, and the treatment of cancer and gynecological, urological, and gastroenterological illnesses and conditions; catheters; diaphragms for holding pharmaceutical preparation to cover the cervix during photoactivation/illumination treatment, or for keeping the pharmaceutical preparation already applied to the cervix in place during photoactivation/illumination treatment; caps for holding a pharmaceutical preparation to cover the cervix during photoactivation/illumination treatment, or for keeping the pharmaceutical preparation already applied to the cervix in place during photoactivation/illumination treatment; light source, namely, light emitting incandescent lamp devices for use in endoscopy and cystoscopy and for the treatment or diagnosis of cancer of the urinary bladder of the urethra, alone or in combination with a pharmaceutical preparation; catheters for installing pharmaceutical preparations into or draining pharmaceutical preparations from the urinary bladder; endoscopy cameras for medical purposes; lamps for medical purposes; urethral probes; urethral syringes; medical apparatus and instruments for the treatment of urological conditions | SECTION 71 - CANCELLED | — |
| 044 | Advisory services relating to health, namely, providing health care advice; advisory services relating to health care; advisory services, namely, providing advice relating to the use of medical apparatus and instruments in providing medical care; advisory services relating to pharmaceutical products; alternative medicine services; analyzing body composition of humans or animals for medical or veterinary purposes; cervical cancer screening services; bladder cancer screening services; consultancy and information services relating to the use of medical products in providing medical care; dermatological services for treating skin conditions; dermatology services; health center services, namely, urgent medical care centers; health clinic services; health consultancy; health counselling; hospital services; medical analysis for the diagnosis and treatment of cancer; medical analysis services relating to the treatment of cancer; medical analysis services relating to the treatment of cancer provided by a medical laboratory; medical and health care clinic services; medical and pharmaceutical consultation; medical and surgical diagnostic testing services; medical and surgical services; medical care; medical care and analysis services relating to patient treatment; medical clinic services; medical consultancy; medical consultations; medical equipment rental; medical screening; medical services; medical diagnostic testing; medical testing for diagnostic or treatment purposes; physical examination; providing cancer screening services; providing information in the field of medicine | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Photocure ASA
- Other trademarks owned by Photocure ASA
- Other trademarks owned by Photocure ASA
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named BLC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 29, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 15, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 15, 2026 | INPC | INVALIDATION PROCESSED | — |
| Sep 26, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 22, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 22, 2024 | C71T | CANCELLED SECTION 71 | — |
| May 8, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 14, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 15, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 20, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 20, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 8, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 8, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 20, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 20, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 31, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 8, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 19, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 18, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 18, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 31, 2017 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Oct 27, 2017 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 14, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 29, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 28, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 21, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 20, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 16, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 15, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |